LXEO — Lexeo Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
U.S. STOCKS ON THE MOVE-Datadog, Terawulf
Lexeo rises as co sets late-stage trial plan for gene therapy in rare heart disease
Brief: Lexeo Therapeutics Announces Regulatory Update And Registrational Trial Design For LX2006 Gene Therapy In Friedreich Ataxia
U.S. STOCKS ON THE MOVE.-CoreWeave, Texas Instruments, Richtech Robotics
U.S. STOCKS ON THE MOVE-Sysco, Corning, HCA Healthcare
U.S. STOCKS ON THE MOVE-RTX, Kimberly-Clark, HCA Healthcare
Lexeo rises as it announces leadership changes
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Lexeo Therapeutics Inc Announces Public Offering And Private Placement For $135 Million
U.S. STOCKS ON THE MOVE- Applovin, Ford Motor, Alto Neuroscience
U.S. STOCKS ON THE MOVE- Veeva Systems, Dell, Nano Nuclear
U.S. STOCKS ON THE MOVE-Constellation Brands, Intercontinental Exchange, IBM
Lexeo Therapeutics rises after positive trial results for heart disease drug
Brief: Lexeo Therapeutics Announces Progress In FDA Discussions For LX006 In Friedreich Ataxia Cardiomyopathy
Brief: Lexeo Therapeutics Appoints Louis Tamayo As CFO
Brief: Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics